[go: up one dir, main page]

DK1513800T3 - Benzoylureido-cinnamic acid derivatives, process for their use - Google Patents

Benzoylureido-cinnamic acid derivatives, process for their use

Info

Publication number
DK1513800T3
DK1513800T3 DK03732438T DK03732438T DK1513800T3 DK 1513800 T3 DK1513800 T3 DK 1513800T3 DK 03732438 T DK03732438 T DK 03732438T DK 03732438 T DK03732438 T DK 03732438T DK 1513800 T3 DK1513800 T3 DK 1513800T3
Authority
DK
Denmark
Prior art keywords
benzoylureido
acid derivatives
cinnamic acid
derivatives
benzoylureidocinnamate
Prior art date
Application number
DK03732438T
Other languages
Danish (da)
Inventor
Karl-Ulrich Wendt
Karl Schoenafinger
Elisabeth Defossa
Dieter Kadereit
Roedern Erich Von
Hans-Joerg Burger
Andreas Herling
Thomas Klabunde
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1513800T3 publication Critical patent/DK1513800T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to N-benzoylureidocinnamate derivatives of formula (I), where R1-R11 have the meanings given in the claims, the physiologically acceptable salts and method for production thereof. The compounds are suitable as anti-diabetics, for example.
DK03732438T 2002-06-07 2003-05-22 Benzoylureido-cinnamic acid derivatives, process for their use DK1513800T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10225635A DE10225635C1 (en) 2002-06-07 2002-06-07 N-benzoylureido-cinnamic acid derivatives, process for their preparation and their use
PCT/EP2003/005355 WO2003104188A1 (en) 2002-06-07 2003-05-22 N-benzoylureidocinnamate derivatives, method for production and use thereof

Publications (1)

Publication Number Publication Date
DK1513800T3 true DK1513800T3 (en) 2007-03-26

Family

ID=29594346

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03732438T DK1513800T3 (en) 2002-06-07 2003-05-22 Benzoylureido-cinnamic acid derivatives, process for their use

Country Status (26)

Country Link
EP (1) EP1513800B1 (en)
JP (1) JP4398859B2 (en)
KR (1) KR20050004295A (en)
CN (1) CN1659137A (en)
AT (1) ATE345326T1 (en)
AU (1) AU2003238373A1 (en)
BR (1) BR0311646A (en)
CA (1) CA2488760A1 (en)
CY (1) CY1106003T1 (en)
DE (2) DE10225635C1 (en)
DK (1) DK1513800T3 (en)
ES (1) ES2277082T3 (en)
HR (1) HRPK20041161B3 (en)
IL (1) IL165558A0 (en)
IN (1) IN2004CH02747A (en)
MA (1) MA27232A1 (en)
MX (1) MXPA04011984A (en)
NO (1) NO20050087L (en)
NZ (1) NZ537004A (en)
PL (1) PL372117A1 (en)
PT (1) PT1513800E (en)
RU (1) RU2004139122A (en)
SI (1) SI1513800T1 (en)
TW (1) TW200404763A (en)
WO (1) WO2003104188A1 (en)
ZA (1) ZA200408887B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179941B2 (en) 2003-01-23 2007-02-20 Sanofi-Aventis Deutschland Gmbh Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
DE10302452B4 (en) * 2003-01-23 2005-02-24 Aventis Pharma Deutschland Gmbh Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use
DE10306502B4 (en) * 2003-02-17 2005-03-17 Aventis Pharma Deutschland Gmbh Substituted 3- (benzoylureido) thiophene derivatives and medicaments containing them
DE10308351A1 (en) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituted cycloalkyl derivatives having acidic, usually heterocyclic groups, processes for their preparation and their use as medicaments
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308355A1 (en) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl-substituted alkanoic acid derivatives, process for their preparation and their use as medicaments
DE10308353A1 (en) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkyl derivatives, processes for their preparation and their use as medicines
DE10308352A1 (en) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Branched side chain arylcycloalkyl derivatives, process for their preparation and their use as medicaments
DE10335092B3 (en) 2003-08-01 2005-02-03 Aventis Pharma Deutschland Gmbh Substituted benzoylureido-o-benzoylamides, process for their preparation and their use
US7241787B2 (en) 2004-01-25 2007-07-10 Sanofi-Aventis Deutschland Gmbh Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
WO2006055435A1 (en) 2004-11-15 2006-05-26 Bristol-Myers Squibb Company 2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
US7226942B2 (en) 2004-11-15 2007-06-05 Bristol-Myers Squibb Company 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006053274A2 (en) 2004-11-15 2006-05-18 Bristol-Myers Squibb Company 2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7365061B2 (en) 2004-11-15 2008-04-29 Bristol-Myers Squibb Company 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
DE102005026762A1 (en) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
TW200718691A (en) * 2005-06-10 2007-05-16 Sigma Tau Ind Farmaceuti Cinnamic and phenylpropiolic acid derivatives useful as anti-tumour agents
PE20080251A1 (en) 2006-05-04 2008-04-25 Boehringer Ingelheim Int USES OF DPP IV INHIBITORS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL141381B (en) * 1963-09-25 1974-03-15 Hoechst Ag METHOD FOR PREPARING MEDICINAL PRODUCTS WITH BLOOD SUGAR MIRROR LOWERING EFFICACY.
GR860542B (en) * 1985-03-01 1986-06-25 Duphar Int Res Benzoyl urea derivatives having antitumor activity
JPS62111961A (en) * 1985-09-30 1987-05-22 ユニオン・カ−バイド・コ−ポレ−シヨン Insecticidal 1-(4-aryloxyphenyl)-3-benzoyl urea compound andits production
DE4037112A1 (en) * 1990-11-22 1992-05-27 Thomae Gmbh Dr K NEW PYRIDYL DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
DK0832066T3 (en) * 1995-06-06 2001-11-19 Pfizer Substituted N- (indole-2-carbonyl) amides and derivatives as glycogen phosphorylase inhibitors
AR028253A1 (en) * 2000-03-16 2003-04-30 Pfizer Prod Inc INHIBITORS OF THE GLUCOGENO FOSFORILASA
YU91002A (en) * 2000-06-09 2006-05-25 Aventis Pharma Deutschland Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament
GB0021831D0 (en) * 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
IN2004CH02747A (en) 2006-02-10
NO20050087L (en) 2005-01-06
HRPK20041161B3 (en) 2006-09-30
ES2277082T3 (en) 2007-07-01
SI1513800T1 (en) 2007-04-30
ATE345326T1 (en) 2006-12-15
AU2003238373A1 (en) 2003-12-22
RU2004139122A (en) 2005-06-10
NZ537004A (en) 2006-06-30
HRP20041161A2 (en) 2005-04-30
MA27232A1 (en) 2005-02-01
JP2005529164A (en) 2005-09-29
CN1659137A (en) 2005-08-24
JP4398859B2 (en) 2010-01-13
BR0311646A (en) 2005-03-15
TW200404763A (en) 2004-04-01
ZA200408887B (en) 2005-11-23
CA2488760A1 (en) 2003-12-18
EP1513800A1 (en) 2005-03-16
MXPA04011984A (en) 2005-03-07
KR20050004295A (en) 2005-01-12
EP1513800B1 (en) 2006-11-15
PT1513800E (en) 2007-02-28
IL165558A0 (en) 2006-01-15
DE50305693D1 (en) 2006-12-28
CY1106003T1 (en) 2011-04-06
PL372117A1 (en) 2005-07-11
DE10225635C1 (en) 2003-12-24
WO2003104188A1 (en) 2003-12-18

Similar Documents

Publication Publication Date Title
TNSN04199A1 (en) Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
MXPA03009840A (en) Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments.
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
DK1513800T3 (en) Benzoylureido-cinnamic acid derivatives, process for their use
UA86760C2 (en) Substituted n-arylheterocycles, method for production and use thereof as medicaments
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
NO20062020L (en) 1-Amino-2-Oxy-Substituted Tetrahydronaphthalene Derivatives, Methods of Preparation thereof, and Their Use as Antiflogistics
CY1106752T1 (en) DIHDROPTERIDINONES, METHOD FOR THEIR PRODUCTION AND THEIR USE AS DRUGS
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
MY139303A (en) Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
UA83875C2 (en) Quinoline derivatives for use as mycobacterial inhibitors
CY1111327T1 (en) Substituted cyclohexylacetic acid derivatives
TW200738692A (en) New substituted glycinamides, process for their manufacture and use thereof as medicaments
NO20070089L (en) DPP-IV inhibitors
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
IL176914A0 (en) Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
ATE438617T1 (en) SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES
IL176915A0 (en) Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
CO5690587A2 (en) BENSOILUREIDOPIRIDIL-PIPERIDIN-Y PIRROLIDIN CARBOXILICO ACID DERIVATIVES, METHOD FOR PRODUCTION AND USE
TW200740798A (en) Substituted amides, process for their manufacture and use thereof as medicaments
ATE471312T1 (en) DIARYLTRIAZOLEMETHYLAMINE DERIVATIVES AND THEIR PRODUCTION AND THERAPEUTIC USE
WO2003070696A3 (en) Substituted aryl ketones
MY139549A (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
ATE401294T1 (en) POLYISOPRENYL-BENZOPHENONE DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF